Cargando…
Medium & long-chain acylcarnitine’s relation to lipid metabolism as potential predictors for diabetic cardiomyopathy: a metabolomic study
BACKGROUND: Acylcarnitine is an intermediate product of fatty acid oxidation. It is reported to be closely associated with the occurrence of diabetic cardiomyopathy (DCM). However, the mechanism of acylcarnitine affecting myocardial disorders is yet to be explored. This current research explores the...
Autores principales: | Zheng, Dan-meng, An, Zhen-ni, Ge, Ming-hao, Wei, Dong-zhuo, Jiang, Ding-wen, Xing, Xue-jiao, Shen, Xiao-lei, Liu, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562007/ https://www.ncbi.nlm.nih.gov/pubmed/34727932 http://dx.doi.org/10.1186/s12944-021-01576-9 |
Ejemplares similares
-
Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
por: Nowak, Christoph, et al.
Publicado: (2018) -
Medium Chain Acylcarnitines Dominate the Metabolite Pattern in Humans under Moderate Intensity Exercise and Support Lipid Oxidation
por: Lehmann, Rainer, et al.
Publicado: (2010) -
NMR Characterization of Long-Chain Fatty Acylcarnitine Binding to the Mitochondrial Carnitine/Acylcarnitine Carrier
por: Zhang, Ningning, et al.
Publicado: (2022) -
Targeted metabolomics for serum amino acids and acylcarnitines in patients with lung cancer
por: Ni, Junjun, et al.
Publicado: (2019) -
Long-Chain Acylcarnitines Regulate the hERG Channel
por: Ferro, Fabio, et al.
Publicado: (2012)